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Terminally differentiated keratinocytes are dead enucleated squams. We showed previously that the mitochondria-
dependent cell death pathway might be gradually activated as differentiation progresses. In this study, we dem-
onstrated that protoporphyrin IX, staurosporine, and rotenone induced apoptotic-like changes in the mitochondria,
and early differentiation of keratinocytes without inducing apoptosis. Kinetics studies established that differen-
tiation-related changes, including growth arrest, ﬂattened morphology, stratiﬁcation, and keratin 10 (K10) expres-
sion, were downstream of mitochondrial depolarization and proliferation, reactive oxygen species (ROS)
production, and release of cytochrome c and apoptosis-inducing factor. When these changes were prevented by
overexpressing Bcl-2 or pharmacologically decreasing the ROS level, K10 upregulation was inhibited, implying that
the differentiated phenotype and K10 expression require apoptotic mitochondria, ROS being the most likely dif-
ferentiation-mediating factor. Our data also suggest that the same mitochondria-affecting stimuli can induce either
differentiation or apoptosis, depending on the keratinocyte’s competency to undergo differentiation, a competency
that may be controlled by Bcl-2.
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Cells of the continuously renewing tissues, including lining
epithelia, epidermis, and blood, proliferate to undergo ter-
minal differentiation, culminating with cell death. To maintain
tissue homeostasis, a balance between cell proliferation,
differentiation, and cell death has to be rigorously controlled
by mechanisms coordinating these processes. It is now well
established that genes controlling cell proliferation are also
involved in the regulation of apoptosis (Sears and Nevins,
2002; Bonnefoy-Berard et al, 2004). Likewise, the cell cycle
is a key coordinator of cell differentiation and has to be
irreversibly inhibited at the onset of phenotypic changes.
Any disturbance of this requirement directs cells toward
apoptosis, implying a regulatory connection between dif-
ferentiation and cell death pathways (for a discussion, see
Anderreeff, 2000; Von Wangenheim and Peterson, 2001).
Indeed, available evidence shows that factors that have
generally been considered as apoptosis specific are often
involved in the regulation of differentiation (Schwerk and
Schulze-Osthoff, 2003; Testa, 2004), arguing strongly for
a mechanistic interaction between differentiation and
apoptosis. How these processes interconnect and/or are
coordinated, however, is still poorly understood. We used
human epidermal keratinocytes as a model to investigate
the relationships between differentiation and the cell death
machinery.
The epidermis is particularly well suited for this type
of study, because the mechanisms controlling epidermal
differentiation are coordinated with cell position in the ep-
idermal strata (Fuchs, 1990; Denning, 2004). Basal undif-
ferentiated keratinocytes both in vivo and in vitro are small
cells that express keratins 5 and 14 (K5 and K14), whereas
maturing keratinocytes detach from the basal lamina, en-
large, flatten, and express early—K1 and K10—and then
late markers of differentiation. The final step of terminal dif-
ferentiation, e.g. a programmed cytoplasmic and nuclear
destruction converting the live keratinocytes into dead
corneocytes, is a cluster of events involved in classical
apoptosis, including caspase-3 activation (Weil et al, 1999;
Allombert-Blaise et al, 2003), chromatin condensation
(Karasek et al, 1972), and DNA fragmentation to nu-
cleosomal size (McCall and Cohen, 1991). We suggested,
based on these parallels, that the apoptotic machinery may
be a part of keratinocyte differentiation processes (Pol-
akowska and Haake, 1994). A mechanistic connection be-
tween these two pathways was supported by correlative
evidence showing a coordinate and progressive appear-
ance of the mitochondria-dependent cell death pathway
markers with keratinocyte position in the epidermal strata
(Allombert-Blaise et al, 2003). Changes in mitochon-
drial function, morphology, and mass that accompanied1These authors contributed equally to this work.
Abbreviations: AIF, apoptosis-inducing factor; Dioc6(3), 3,3
0di-
hexyloxacarbocyanineiodide; EM, electron microscopy; FITC, flu-
orescein isothiocyanate; K10, keratin 10; MTG, MitoTracker Green;
NHK, normal human keratinocyte; PBR, benzodiazepine receptor;
PPIX, protoporphyrine IX; ROS, reactive oxygen species; ROT,
rotenone; STS, staurosporine
Copyright r 2005 by The Society for Investigative Dermatology, Inc.
647
differentiation were also documented in muscle (Rochard
et al, 2000), colon carcinoma (Mancini et al, 1997), ad-
ipocyte (Wilson-Fritch et al, 2003), or chondrocyte (Tona-
chini et al, 2004) cellular systems, strongly suggesting that
mitochondria are actively involved in this process.
Mitochondria play a pivotal role in eucaryotic cells by
producing cellular energy in the coupling respiratory chain
reaction (complex I–IV), converting high-energy electrons
into an electrochemical gradient across the inner mi-
tochondrial membrane, to oxidative phosphorylation ulti-
mately generating ATP (complex V). As a side effect of the
respiratory chain activity, a small but constant portion of
oxygen is converted into superoxide. Under normal condi-
tions, superoxide is converted into hydrogen peroxide
(H2O2) and then into water by the superoxide dismutase
and catalase and/or glutathione peroxidase, respectively, to
maintain redox homeostasis in the cell. The antioxidative
system, however, is not fully efficient and it has been es-
timated that the mitochondrial membrane is the most
important source of reactive oxygen species (ROS) in non-
immune cells. The intracellular ROS level partly depends on
substrate and oxygen availability, on mitochondria biogen-
esis, and on mitochondria integrity. When controlled and in
modest quantities, ROS are thought to modify regulatory
molecules and trigger cellular signaling pathways, to control
proliferation and differentiation, when sustained to contrib-
ute to aging, and when randomly or excessively released
to induce programmed cell death (see Droge, 2002 for a
review).
The conversion of apoptotic signals induced by stress,
including oxidative stress, is the second most important
function of mitochondria after energy production (Cande
et al, 2004; Danial and Korsmeyer, 2004). This function,
however, is associated with mitochondrial impairment, trig-
gering cytochrome c, and apoptosis-inducing factor (AIF)
release from compromised mitochondria and activation of
caspase-dependent and -independent cell death pathways,
respectively. The apoptotic activity of mitochondria is reg-
ulated by the Bcl-2 family, which either guards (anti-apo-
ptotic) or disrupts (pro-apoptotic) mitochondrial membrane
integrity. Recently, it was shown that apoptosis is also as-
sociated with changes in mitochondrial mass consistent
with mitochondrial fission (Karbowski and Youle, 2003). In-
terestingly, mitochondrial fission does not always correlate
with apoptosis: as mentioned above, similar changes were
observed during cellular differentiation (Mancini et al, 1997;
Rochard et al, 2000; Allombert-Blaise et al, 2003; Wilson-
Fritch et al, 2003; Tonachini et al, 2004). As differentiation
processes can be regulated by the Bcl-2 family (Abraham
and Shaham, 2004) and involve caspase activities (Yuste
et al, 2002), we postulated (Allombert-Blaise et al, 2003) that
the mitochondria-dependent cell death machinery may be
required for differentiation.
To provide experimental evidence, we sought to learn
whether induction of apoptotic-like changes in mito-
chondria could affect keratinocyte differentiation. We found
that, in keratinocytes, the apoptotic-like mitochondrial
changes impinged on the differentiation-related changes,
thus supporting the concept of epidermal differentiation
being dependent on mitochondria-mediated apoptotic
machinery.
Results
To address the question of whether mitochondrial changes
can influence keratinocyte differentiation, undifferentiated
human primary keratinocytes and HaCaT cells were treated
with well-known inducers of mitochondrial dysfunction:
protoporphyrine IX (PPIX), a ligand of the peripheral ben-
zodiazepine receptor (PBR) located within the mitochondrial
outer membrane, staurosporine (STS), a general inhibitor of
protein kinases, and rotenone (ROT), an inhibitor of complex
I in the respiratory chain. The selection of inducers with
different mechanisms of action upstream of mitochondrial
impairments but commonly targeting mitochondria provid-
ed a control for their nonmitochondrially derived effect. Mi-
tochondrial and differentiation-associated changes as well
as apoptosis were then compared and analyzed.
Inducers of apoptosis-related mitochondria dysfunction
induced differentiation-associated changes in HaCaT
and primary keratinocytes When epidermal keratinocytes
enter the differentiation program, they stop expressing K5
and K14 and start expressing K10 and involucrin, markers
of early differentiation (Fuchs, 1990). As judged by an in-
creased number of cells positively stained with anti-K10
fluorescein isothiocyanate (FITC) (Fig 1A) and anti-involucrin
Figure1
Protoporphyrine IX (PPIX), staurosporine (STS), and rotenone
(ROT) induce keratin 10 (K10) expression and the associated dif-
ferentiated phenotype in human keratinocytes. (A–C HaCaTcells) (A)
Cells grown on chamber slides were treated with 30 mM PPIX, 5 nM
STS, and 250 nM ROT for 24 h. K10-positive cells were detected by
fluorescein isothiocyanate (FITC)-labeled antibody (left) and nuclei re-
flecting cell density by DAPI (right), scale bar¼ 50 mm. Western blot (B)
and RT-PCR (C) of proteins and mRNA, respectively, isolated from the
24 h treated and control HaCaT cells. Glyceraldehyde 3-phosphate
dehydrogenase (G3PDH) and b-actin served as gel-loading controls (P,
PPIX; S, STS; and R, ROT). (D) Primary cultures of normal human ker-
atinocytes (NHK) in SFM (Ctrl) and in SFM supplemented with PPIX for
24 h were stained with anti-K10 FITC antibody and analyzed by flow
cytometry. Spectrum profile shows a shift of K-10-positive cells in a cell
population of large cells gated (R1—left inset) according to cellular
size (FS) and granulosity (SS). Inset (right) shows phase contrast
microscopy images of the same cells before and after treatment,
scale bar¼10 mm. Representative data of two to five independent
experiments.
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(not shown) in treated versus untreated HaCaT cultures,
PPIX, STS, and ROT all induced expression of differentiation
markers and stratification, despite their different mecha-
nisms of action. A dose–response study (not shown) deter-
mined that PPIX at a concentration of 30 mM, STS at 5 nM,
and ROT at 0.25 mM induced the maximum level of K10 and
minimum apoptosis after 24 h of treatment. These concen-
trations were used in the subsequent experiments. The up-
regulation of K10 in the treated cultures was confirmed by
western blot (Fig 1B). The semi-quantitative RT-PCR anal-
ysis of K10 mRNA (Fig 1C) suggested that K10 induction
was controlled mainly at the level of transcription.
The upregulation of the early differentiation markers was
accompanied by changes in cell morphology, particularly
highly visible in the primary normal human keratinocyte
(NHK) cultures shown on the representative images of PPIX-
treated cells (Fig 1D). The undifferentiated cells became
larger and assumed a flattened morphology characteristic
of differentiating keratinocytes. Morphological changes cor-
related with a shift in the fluorescence peak from lower to
higher intensities, representing K10-positive cells with in-
creased cell size and granulosity (Fig 1D). The level of K10
induction in drug-treated NHK was comparable with that
found in HaCaT cultures, indicating that the effect has more
general implications.
Under normal conditions, keratinocyte differentiation is
preceded by irreversible growth arrest. To determine the cell
cycle phase in which cells express K10, we analyzed by two
parameter-flow cytometry FITC (K10)- and propidium iodide
(PI) (cell cycle)-stained PPIX-, STS-, and ROT-treated Ha-
CaT cells (Fig 2A). The diagrams showed that the K10 FITC
label accumulated mainly in the subpopulation of G0/G1-
arrested cells. A colony-forming assay revealed that relative
to the control, 37% and 32% of live HaCaT cells and 41%
and 50% NHK lost their ability to form colonies after 24 h
treatment with PPIX and ROT, respectively. This coincided
with similar percentages of K10-positive HaCaT cells in a
G0/G1 subpopulation, implying that these cells irreversibly
arrested their cycle before entering differentiation.
The PPIX-, STS-, and ROT-induced K10 was associated
with very low levels of apoptosis detected by the sub-G1
fraction of the cell cycle (Fig 2A), trypan blue exclusion, and
TUNEL assays (not shown). Apoptosis, however, was not
a dominant event in these cultures, and the majority of
cells retained their normal phenotype even 7 days after
treatment. Interestingly, in the apoptotic compartment, im-
munohistochemistry of PPIX- (Fig 2B), STS-, and ROT-
treated (not shown) HaCaTcells revealed that the majority of
attached cells with classical apoptotic nuclei were indeed
K10 negative, whereas the K10-positive cells had normal
nuclei (Fig 2B, left). This implies that apoptosis-sensitive
cells might be the cells that do not express K10, and dem-
onstrates that attached K10-positive cells are not apoptotic,
at least at the time of the analysis. It should be noted,
however, that K10-positive cells with apoptotic-like nuclei
(Leist and Jaattela, 2001) were also found, although often in
the supernatant of cultures treated for 24 h (Fig 2B, right).
These data suggest that cell detachment could be a con-
sequence of K10 expression and in vitro progression in the
differentiation-related stratification, followed by nuclear
changes atypical to classical apoptosis.
Induction of K10 was associated with an increase in
mitochondrial mass and changes in mitochondrial mor-
phology In order to determine whether mitochondrial im-
pairments were responsible for the differentiation-related
changes, it was necessary to show that each of the selected
drugs affects mitochondria to a similar extent. First, we
studied changes in mitochondrial mass, as proliferation of
mitochondria was shown to precede apoptosis (Mancini
et al, 1997; Karbowski and Youle, 2003). If mitochondria
change in the differentiating K10-expressing keratinocytes,
PPIX, STS, and ROT, all inducers of K10 expression should
affect the biogenesis of mitochondria. Indeed, as shown in
Fig 3A, the uptake of mitochondria-specific dye MitoTracker
Green (MTG) increased in the subpopulation of stimulated
HaCaT cells. Heterogeneous, low- and high-intensity fluo-
rescent cells became highly fluorescent after 24 h treat-
ment, with a dramatic shift from a lower to a higher content
of MTG starting as early as 1 h after treatment (Fig 9). The
most likely interpretation is that this shift reflects an increase
Figure 2
Mitochondria-targeting stimuli induced keratin 10 (K10) in the cell
cycle-arrested keratinocytes but little or no apoptosis. (A) Two-
parameter (propidium iodide (PI) cell cycle and fluorescein isothiocyan-
ate (FITC) K10) flow cytometry analysis of HaCaT cells grown for 24 h in
the presence and absence of the indicated drugs after staining with PI
and with K10-FITC-secondary antibody. Lines indicate gates for each
phase, and numbers indicate the percentage of cells per gate. (B) Flu-
orescent microscope captured a representative image of PPIX treated
(24 h) attached (left, scale bar 10 mm) and detached (right, scale bar 20
mm) HaCaT cells stained with anti-K10 antibody (secondary antibody:
either FITC or Texas Red conjugated) and DAPI dye (blue) to visualize
nuclei. Arrow indicates apoptotic nucleus. Notice that K10-positive
cells are flat and stratified with nuclei that appear normal.
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in mitochondrial mass. We cannot exclude, however, that
the repeatable presence of low-intensity fluorescent cells in
the control cultures may also reflect functional differences
between HaCaT cells contributing to the differential MTG
uptake. To test these possibilities, we created HaCaT cells
with fluorescent mitochondria using BD Biosciences’ pHc-
Red1-Mito vector and treated them with PPIX, STS, and
ROT for 24 h. The flow cytometry profile of the HcRed1
fluorescence (not shown) mirrored the profile of the second
peak in the MTG-based experiments (Fig 3A), implying
this peak as being more relevant to the actual changes in
mitochondrial mass. Importantly, this interpretation is sup-
ported by results obtained with cells freshly isolated from
the native epidermis. Also, here, a subpopulation of small
undifferentiated cells (K14 positive, K10 negative, not
shown) was heterogeneous in terms of MTG content,
whereas the subpopulation of larger, differentiating cells
had a high MTG content (Fig 3B). The increase in fluores-
cence signal emitted by the freshly isolated cells, however,
clearly reflected changes in mitochondrial mass, as the
number of the MTG-loaded mitochondria, seen on the con-
focal microscopy images, increased with increasing cell
size (Fig 3C). Further evidence was provided by electron
microscopy (EM) images (Fig 4), showing that changes in
the mitochondrial mass were associated with changes in
the size, number, and morphology of mitochondria. Mi-
tochondria of the PPIX-treated cells were almost twice as
numerous as in the untreated control (Fig 4A). The physi-
ological relevance of these changes is once again support-
ed by similar observations in the native epidermis (Fig 4B
and Ronquist et al, 2003), although size and morphological
alterations appear to be more accentuated in vitro than
in vivo.
Drug-induced upregulation of K10 was preceded by mi-
tochondrial changes generally considered to accompa-
ny apoptosis Mitochondrial proliferation, decrease in
mitochondrial transmembrane electric potential (DCm), and
increase in ROS production are generally considered to be
good indicators of mitochondrial impairment (Crompton,
1999; see Droge, 2002). Thus, we studied the kinetics of
DCm and ROS changes in treated and untreated HaCaT
cells and related these to the expression of differentiation
markers and apoptosis. As shown in Fig 5, PPIX, STS, and
ROT reduced DCm within the first 3 h. The effect was time
dependent and at 24 h, 75%–90% of treated cells exhibited
low DCm. The decrease in DCm was followed by an increase
in ROS production with a 6–12 h delay, and then by the
induction of K10 expression. K10 induction was associated
with a very low level of apoptosis. This time course study
shows that, although PPIX, STS, and ROT exhibit slightly
different kinetics of action, K10 induction was either pre-
ceded or coincided by a decrease in DCm and an increase
in ROS production, suggesting that mitochondrial impair-
ment may be a prerequisite for the expression of an early
differentiation phenotype.
The two-parameter flow cytometry analysis of ROS and
DCm revealed that only 25%–45% of cells with de-ener-
gized mitochondria contained an increased level of the in-
tracellular ROS (Fig 5B, representative data) potentially
harmful to the cell. Interestingly, this corresponded to the
percentage of K10-positive keratinocytes in the very same
cultures. As K10-positive cells were within the larger cell
subpopulation (Fig 1D) and had more and depolarized mi-
tochondria (Fig 3B, C), we speculate that ROS may be in-
volved in the control of K10 expression by a subset of cells
with de-energized mitochondria.
Calcium-induced keratinocyte differentiation associated
with mitochondrial changes To validate the physiological
relevance of the above findings, we had to demonstrate that
similar events take place in normal keratinocytes stimulated
Figure 3
Mitochondria of stimuli-induced or in vivo-differentiating keratin-
ocytes accumulated more MitoTracker Green (MTG) dye than mi-
tochondria in non-stimulated or undifferentiated cells. (A) The mean
fluorescence staining intensity determined by flow cytometry before
(white) and after 24 h of treatment with PPIX, STS, and ROT (gray)
identified low and highly fluorescing mitochondria in control cells and
almost exclusively highly fluorescing mitochondria in treated HaCaT
cells. Arrows indicate a shift in the second peak that most likely reflects
changes in mitochondrial mass. (B) MTG-stained cells in native human
epidermis were analyzed by two-parameter flow cytometry: size (FS,
forward scatter) and granularity (SS, side scatter) versus fluorescence
intensity (FL1-FITC). Smaller cells were identified as undifferentiated,
and larger cells as differentiated (data not shown). Representative data
of at least three independent experiments. (C) Confocal microscopy of
attached cells freshly isolated from the native human epidermis and
stained with CMX-ROS (red) and MTG (green), life indicators of DCm
and mitochondrial mass, respectively. Compare mitochondrial mass in
cells pointed by arrows and note that large cells (K10 positive not
shown) lost their DCm (CMX-ROS
dim), whereas small cells did not (yel-
low¼ superimposed green and red).
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to differentiate by using in vivo-like conditions. Calcium is a
well-established stimulus of keratinocyte differentiation
both in vivo and in vitro (see Fuchs, 1990; Bikle et al,
2004). If differentiation-related changes depend on the al-
terations in mitochondria, we should observe mitochondrial
changes in the Ca2þ -induced differentiating NHK similar to
those found in the drug-induced HaCaT cells. As expected,
a population of NHK grown with low Ca2þ was heteroge-
neous and consisted of cells with high and low DCm.
Switching to high Ca2þ resulted in a decrease in mi-
tochondrial membrane potential in the high-DCm subpop-
ulation (Fig 6A) associated with an increase in ROS
production (Fig 6B) and K10 expression (Fig 6C). Flow
cytometry analysis (FS vs FL1 channel) of K10-labeled cells
estimated that a shift in the fluorescence intensity was re-
lated to the larger-differentiating cells and increased from
5.1% in the control cultures to 42.5% after calcium treat-
ment. These data suggest the physiological relevance of the
drug-induced events affecting mitochondria and differenti-
ation of epidermal keratinocytes.
Figure4
Electron microscopy (EM) determined mitochondria morphology,
size, and number change in HaCaT cells upon protoporphyrine IX
(PPIX) treatment and in undifferentiated and differentiating kera-
tinocyte of the native epidermis. Epidermal samples and PPIX-treat-
ed (24 h) HaCaT cells were prepared for EM as described in Material
and Methods. (A) Representative images show ultrastructure of un-
treated (left) and PPIX-treated (right) cells. PPIX augmented the size
and number of mitochondria per unit (9 mm2) as estimated based on
EM images. Arrows point to selected mitochondria. Note the differ-
ences in the cristae complexity of mitochondria in addition to the
increased size and number. Scale bar¼1 mm. (B) Number of
mitochondria per cell also increases in the native human epidermis
as cells move from basal to suprabasal layers. The electron microscopy
images of the representative basal (left) and suprabasal (right) cells in
the same sample of the normal human epidermis are shown. Arrow
points to the basement membrane,and arrowheads point to some mi-
tochondria. A difference in the mitochondria number (A and B) was
determined by the two-tailed Man–Whitney U test showing statistical
significance (po0.002) between control and treated cells and between
basal and suprabasal keratinocytes. Magnification  7000.
Figure5
Apoptotic-like mitochondrial changes precede keratin 10 (K10) in-
duction. (A) Kinetics of PPIX-, STS-, and ROT-induced changes in the
mitochondria transmembrane electric potential (DCm) and reactive ox-
ygen species (ROS) production in relation to K10 expression and
apoptosis, assayed in HaCaT cells by flow cytometry. To determine
DCm, cells were stained with Dioc6(3), HE was used to estimate ROS
production, and FITC-conjugated antibody was used to estimate the
number of K10-positive cells. Apoptosis was determined by a flow
cytometry analysis of propidium iodide (PI)-positive cells with a sub-G1
content of DNA. (B) Two-parameter flow cytometry of stimuli-treated
HaCaT cells (24 h) showing distribution of cells according to their DCm
(FL1-Dioc6(3)) and ROS content (FL2-HE). Data are the mean of three to
five independent experiments.
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Pharmacological depletion of Ca2þ decreases ROS pro-
duction and K10 expression An increase in the extracel-
lular Ca2þ concentrations leads to an increase in cytosolic
Ca2þ and an overload of Ca2þ in mitochondria, which de-
polarize and consequently generate more ROS (Crompton,
1999). We assumed therefore that if the mitochondria-trig-
gering stimuli affect Ca2þ homeostasis in the treated cells,
a chelator of intracellular Ca2þ including BAPTAAM should
prevent ROS production and the expression of the differ-
entiated phenotype. As shown in Fig 7A, BAPTA did not
affect the mitochondria membrane potential. Addition of 2.5
mM BAPTA, however, dramatically decreased, the level of
the PPIX- and ROT-induced ROS and accordingly, K10 ex-
pression at the antigen level.
As the RT-PCR data suggested transcriptional regulation
of K10 expression in response to the mitochondria-affecting
stimuli, we tested K10 promoter activity using a K10-CAT
reporter in transfected HaCaT and NHK. The K10-CAT re-
porter activity was significantly elevated in the stimulated
HaCaT and NHK (Fig 7B) cultures, as judged by the CAT
level in ELISA assays. The stimulation appeared specific to
the K10 promoter because under the same conditions, the
NF-kB-Luc reporter remained inactive (not shown). In con-
cordance with the K10 antigen data, BAPTA also prevented
the PPIX-, ROT-, and Ca2þ -triggered activation of the K10
promoter, demonstrating that K10 expression is controlled
at the transcriptional level and may depend on the elevated
intracellular Ca2þ concentrations. Indeed, PPIX (Fig 7C)
and ROT (not shown) increased intracellular Ca2þ concen-
trations in the HaCaT cells and BAPTA prevented this in-
crease. As BAPTA also prevented ROS production, normally
associated with K10 upregulation, it was likely that the
transcriptional activity of the K10 promoter was regulated
by Ca2þ -dependent redox signaling.
Antioxidants inhibit transcriptional activity of K10 pro-
moter and prevent K10 antigen expression If ROS were
responsible for K10 upregulation, a decrease in oxidative
stress should prevent K10 induction. Antioxidants, including
catalase and non-enzymatic N,N0-diphenyl-p-phenylenedia-
mine (DPPD) or a-tocopherol (vitamin E), were added to
HaCaT cells 30 min before treatment with PPIX and ROT.
The DCm, ROS level and K10 upregulation were measured
by flow cytometry 24 h later. Antioxidants had almost no
effect on the DCm whereas lowering the intracellular ROS
(Fig 8A), suggesting that ROS are not responsible for the
de-energized mitochondria in the drug-treated cells. Anti-
oxidants did, however, significantly decrease the number of
K10-positive cells (Fig 8B). Reduced levels of ROS should
also affect the K10-CAT reporter. Indeed, antioxidants sup-
pressed the transcriptional activity of the K10-CAT reporter
(Fig 8B). This phenomenon was not limited to immortalized
cells or to non-physiological stimuli. When we placed NHK
in differentiation-inducing medium containing high calcium
(1.2 mM), or treated them with PPIX or ROT in the presence
and absence of antioxidants, we found, a similar effect on
the K10-CAT (Fig 8C) reporter, indicating that K10 tran-
scription is ROS dependent.
Overexpression of anti-apoptotic Bcl-2 inhibited drug-
induced K10 expression The key regulators of change in
the mitochondria are pro-apoptotic and anti-apoptotic
members of the Bcl-2 family (Cande et al, 2004; Danial
and Korsmeyer, 2004). Bcl-2 itself promotes cell survival by
controlling cellular redox and Ca2þ homeostasis and pre-
venting release of apoptotic factors from the mitochondria
(Voehringer and Meyn, 2000; Kuwana and Newmeyer, 2003;
Ouyang and Giffard, 2004). Overexpression of the anti-apo-
ptotic Bcl-2 in HaCaT cells inhibited the decrease in DCm
imposed by PPIX, STS, and ROT in 40%–60% cases, and
this was associated with a higher number of cycling cells
(Fig 9A). ROS production, however, was significantly sup-
pressed in STS- and ROT-treated HaCaT cells only (Fig 9B).
Inhibition of ROS production was directly proportional to the
ability of Bcl-2 to inhibit K10 expression (Fig 9C). K10 in-
duction was suppressed in STS- and ROT-treated cultures,
but not in PPIX-treated cells, in which ROS production re-
mained unaffected by Bcl-2 overexpression. To determine
why cells responded differently to PPIX than to other stimuli,
we assessed the Bcl-2 level by western blot, because it was
shown that ligated PBR inhibits Bcl-2 (Fischer et al, 2001).
Indeed, the Bcl-2 level was dramatically decreased in the
PPIX-treated cells but remained unchanged in cells ex-
posed to STS and ROT (Fig 9D). Interestingly, K10 expres-
sion in Bcl-2 overexpressing HaCaT cells was also directly
proportional to the presence of cytosolic AIF and cyto-
chrome c in PPIX-treated cultures (Fig 9D). The exogenous
Bcl-2 unable to prevent AIF and cytochrome c release did
not inhibit K10 expression in PPIX-treated cells. In contrast,
it prevented STS- and ROT-triggered release and inhibited
K10 induction. Interestingly, Bcl-2 also prevented ROT-
induced, but not PPIX-induced, mitochondrial mass as
Figure 6
Ca2þ-induced differentiation of normal human keratinocytes
(NHK) correlates with mitochondrial impairment and keratin 10
(K10) content. Representative flow cytometry analysis of NHK
switched from low (0.05 mM) to high (1.2 mM) Ca2þ in SFM for 24 h
showing: (A) decrease in mitochondrial membrane potential (DCm-
Dioc6(3) staining), (B) increase in reactive oxygen species (ROS HE
staining), and (C) K10 induction (anti-K10-FITC staining) in the control
(left) and treated (right) cultures. Note stratification and large size of the
K10-positive (green) cells. DAPI (blue) visualize nuclei. Scale bar 50 mm.
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indicated by the percentages of the high-MTG-content
subpopulation (Fig 9E). These data demonstrate that just as
for ROS production, an increase in mitochondrial mass as
well as AIF and/or cytochrome c release may be responsible
for induction of K10 expression and suggest that epidermal
differentiation, as apoptosis, may depend on Bcl-2’s ability
to control intracellular ROS, mitochondrial mass, and per-
haps mitochondrial membrane integrity.
Discussion
We have previously shown that progression in keratinocyte
differentiation is coordinated with the gradual expression of
markers of mitochondria-dependent apoptosis (Allombert-
Blaise et al, 2003). This, we speculated, indicates that ker-
atinocyte differentiation is closely linked to the cell death
machinery that, when stepwise activated, converts live cells
into dead corneocytes. In this study, we searched for a
mechanistic connection between the apoptotic and differ-
entiation machineries in epidermal keratinocytes. The aim
was to determine whether mitochondrial changes associ-
ated with apoptosis could induce differentiation signals. To
ensure that signals were mitochondria derived, apoptotic
mitochondria were induced by stimuli differing in their
mechanisms of action but with a common mitochondrial
outcome. We selected PPIX that can directly influence mi-
tochondria, as PBR is a component of the mitochondrial
membrane permeability transition pore associated with
voltage-dependent anion channel. PBR is reported to both
prevent and induce apoptosis (Galiegue et al, 2003). Inter-
estingly, elevated levels of PBR (Stoebner et al, 1999) and
increasing concentrations of endogenous PPIX accompany
keratinocyte differentiation, including differentiation after
calcium stimulation (Ortel et al, 1998). Our finding that ex-
ogenous PPIX induces K10 without inducing apoptosis
agrees with these reports. A second stimulus was STS, a
non-specific protein kinases inhibitor that affects mi-
tochondria function indirectly by modulating signal trans-
duction pathways. STS, in addition to its established ability
Figure 7
Ca2þ chelator (BAPTAAM) inhib-
its protoporphyrine IX (PPIX)-
and rotenone (ROT)-induced
reactive oxygen species (ROS)
production and keratin 10 (K10)
expression at the transcript and
protein level. (A) Flow cytometry
analysis of HaCaT cells showing:
percent of cells with polarized mi-
tochondria (DCm), modulation in
ROS production, and percent of
anti-K10-FITC-positive cells. (B)
Changes in the K10-CAT reporter
activity in HaCaT cultures and NHK
transfected with K10-CAT plasmid
DNA. Note that CAT reporter activ-
ity increased in response to PPIX,
ROT, and Ca2þ stimuli. BAPTA
suppressed this induction. Data
are the mean of two to three inde-
pendent experiments each in three
separate samples. (C) PPIX elevat-
ed intracellular Ca2þ -free concen-
trations [Ca2þ ]free preventable by
BAPTAAM. Changes in [Ca2þ ]free in
control and PPIX-treated HaCaT
cells in the absence and presence
of BAPTA were determined using
500 nM Fluo-3AM indicator.
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to induce mitochondrial dysfunction in different cell types
(Roucou et al, 2001; Charlot et al, 2004), raises intracellular
calcium, and in keratinocytes, stimulates expression of the
differentiation-specific markers and differentiating pheno-
type (Stanwell et al, 1996). Again our data are in agreement
with these findings. Finally, we selected ROT, an inhibitor of
complex I that blocks the respiratory chain reaction. Al-
though it may act as an antioxidant-preventing apoptosis, it
has also been reported to increase ROS production and to
induce apoptosis (Chen et al, 2003). Thus, all three stimuli
are well-established inducers of mitochondrial dysfunction
preceding apoptosis. Our data demonstrated that diverse
stimuli, which induce apoptotic-like changes in mito-
chondria, used at their sub-lethal concentrations, have the
capacity to stimulate phenotypic expression of keratinocyte
differentiation. Keratinocytes in this matter resemble eryth-
rocytes, which also appear to apply the apoptotic machin-
ery to differentiation processes (Testa, 2004). Terminal
differentiation-induced cell death in the epidermis appears
to involve mitochondrial changes very similar to those in-
volved in classical apoptosis, but here their outcome is dif-
ferent. Although the factors responsible for the differences
remain a subject of speculation, we provide some argu-
ments supporting the possibility that induction of mi-
tochondrial impairment will trigger differentiation in cells
committed to undergo maturation processes but apoptosis
in differentiation-incompetent cells.
Link between mitochondria depolarization and keratin-
ocyte growth arrest The earliest common response of
HaCaT keratinocytes to PPIX, STS, and ROT was depolari-
zation of mitochondria and increase in their mass. This ef-
fect was prevented by Bcl-2 overexpression, demonstrating
that in the stimuli-induced keratinocytes these mi-
tochondrial changes are downstream of the Bcl-2 func-
tions, which include controlling cellular Ca2þ and redox
homeostasis (Voehringer and Meyn, 2000; Kuwana and
Newmeyer, 2003; Ouyang and Giffard, 2004), mitochondrial
membrane integrity, and regulation of G0/G1 to S-phase
transition of the cell cycle (Bonnefoy-Berard et al, 2004;
Boonstra and Post, 2004; Green and Kroemer, 2004).
Intriguingly, 40%–60% of the Bcl-2 overexpressing cells
that maintained a high DCm appeared to be in the S-phase
of the cell cycle. In contrast, in the control cells low DCm
correlated with growth arrest. This suggests a direct rela-
tionship between the energetic status of mitochondria and
the phase of the cell cycle. The link between low DCm and
quiescence was demonstrated in hematopoietic stem cells
Figure 8
Antioxidants inhibit reactive ox-
ygen species (ROS) production
and suppress keratin 10 (K10)
expression. Flow cytometry anal-
ysis of HaCaT cells showing: (A) no
change in DCm (Dioc6(3) label) and
reduced level of ROS (HE label), (B)
the corresponding decrease in the
anti-K10-FITC positivity and K10-
CAT reporter activity in response to
treatment (24 h) with mitochondria-
triggering stimuli (protoporphyrine
IX (PPIX) and rotenone (ROT)) in
the presence and absence of anti-
oxidants (vitamin E, DPPD, and
catalase). (C) Antioxidants also de-
creased K10-CAT reporter activity
in the stimuli (PPIX, ROT, Ca2þ )-
treated NHK. Data are the mean of
two to three independent experi-
ments in three separate samples.
Statistically significant (po0.04).
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(Kim et al, 1998), transformed fibroblasts (Kunz-Schughart
et al, 2001), and, very recently, also in Ca2þ -treated HaCaT
cells (Savignan et al, 2004). Moreover, we have previously
shown that the majority of cells in the proliferative com-
partment of the native epidermis contained fewer but highly
energized mitochondria. Their depolarization correlated with
the differentiated phenotype of non-cycling cells and with
an increase in their number (Allombert-Blaise et al, 2003).
Mitochondrial proliferation associated with depolarization,
clearly seen in the subpopulation of larger, K10-positive
cells (Figs 1D and 3C), also preceded Herbimycin A-in-
duced Colo-205 cell growth arrest and differentiation (Man-
cini et al, 1997). This concords with the idea that an increase
in mitochondrial mass ensures the high mitochondrial-to-
nuclear-genome ratio required for growth arrest (Von Wan-
genheim and Peterson, 2001, Duguez et al, 2004). Again,
Bcl-2 prevented an increase in mitochondrial mass (Fig 9
and Eliseev et al, 2003), demonstrating a link between the
reduction in mitochondrial potential, growth arrest, and
proliferation of mitochondria.
To summarize, it appears that cell proliferation requires
high DCm and fewer mitochondria, and that more numerous
and de-energized mitochondria correlate with growth arrest
and keratinocyte differentiation both in vivo and in vitro. It
also appears that the switch between these two types of
mitochondria may be regulated by Bcl-2.
Bcl-2 inhibits K10 expression associated with the early
keratinocyte differentiation by suppressing ROS gener-
ation and cytochrome c release K10 upregulation was
preceded by the increase in mitochondrial permeability re-
sulting in cytochrome c and AIF release. Mitochondrial
membranes, however, remained intact in cultured (PPIX
treated) and native keratinocytes, excluding membrane
rupture as a possible mechanism of release during differ-
entiation. Whatever the mechanisms (see Green and
Kroemer, 2004 for a discussion), cytochrome c and AIF re-
lease were associated with K10 upregulation (confirmed by
microinjection of cytochrome c—manuscript in preparation).
The finding that AP-2 activity is also regulated by cytoplas-
mic cytochrome c in the absence of apoptosis (Grether-
Beck et al, 2003) strengthens our results, suggesting that
cytochrome c and/or ROS may transmit a signal from mi-
tochondria to the nucleus in a Bcl-2-dependent manner, as
proposed for Hl-60 cells (Eliseev et al, 2003).
Very little is known about ROS signaling during keratin-
ocyte differentiation, and the limited data are not always
consistent (Ellisen et al, 2002; Savini et al, 2003; Eckert et al,
2004). In other cellular systems, moderate amounts of ROS
act as a second messenger, controlling cell proliferation and
differentiation (see Droge, 2002; Finkel, 2003). Factors that
regulate intracellular ROS levels, and therefore cell fate, in-
clude Ca2þ and Bcl-2. The Ca2þ gradient present in the
epidermis (Bikle et al, 2004) may create an ROS gradient.
Although the existence of an ROS gradient awaits investi-
gation, it is important to note that Bcl-2 had a capacity to
lower the levels of ROS and to prevent K10 upregulation in
the Bcl-2 overexpressors. As Bcl-2 expression in the normal
epidermis is limited to the K10-negative basal cells (see
Weisfelner and Gottlieb, 2003), where the lowest level of
intracellular Ca2þ is also found, it is reasonable to assume
Figure 9
Bcl-2-dependent inhibition of reactive oxygen species (ROS) pro-
duction downregulates keratin 10 (K10) expression. HaCaT controls
(white) and Bcl-2 overexpressing cells (black) were treated as indicated
and stained before flow cytometry analysis. (A) DiOC6(3) staining for
DCm 24 h after treatment. Corresponding numbers in the inset indicate
% of cells in the S-phase of the cell cycle. (B) HE staining measuring
intracellular ROS. (C) Anti-K10-FITC staining. Data are the mean of
three to five independent experiments. (D) Effect of Bcl-2 on apoptosis-
inducing factor (AIF) and cytochrome c release in relation to K10 in-
duction. Western blot of lysates isolated from HaCaT-Bcl-2 cells
untreated and treated with protoporphyrine IX (PPIX) (P), staurosporine
(STS) (S), and rotenone (ROT)(R) for 6 h to determine AIF and cyto-
chrome c release and for 24 h to determine keratin 10 and Bcl-2 levels.
Compare western blot on Figs 1B and 9D for differences in K10 ex-
pression between HaCaT and HaCaT-Bcl-2 cells, and note that K10
upregulation and cytochrome c/AIF release was only observed in PPIX-
treated cells in which Bcl-2 level was dramatically decreased. (E) Over-
expression of Bcl-2 prevented increase in mitochondrial mass in ROT
but not in PPIX-treated cultures. Flow cytometry analysis of MTG-
labeled HaCaTand HaCaT-Bcl-2 cells. Histograms show changes in the
subpopulation of cells containing high MTG only. Representative data
of at least three independent experiments. Statistically significant
(po0.04) difference between control and Bcl-2 overexpressors.
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that Bcl-2, which controls both Ca2þ and redox home-
ostasis, operates as an ROS and differentiation-preventing
factor in the basal compartment. The in vitro studies (Fig 9
and Harada et al, 1998) support this interpretation. Bcl-2
disappearance in the suprabasal cells correlates with the
expression of K10 and associated stratification (Reichelt
and Magin, 2002). Interestingly, neither the overexpression
of Bcl-2 using K1 promoter in suprabasal cells of recon-
structed skin (Rodriguez-Villanueva et al, 1998) nor the
overexpression of Bcl-xL in basal cells of transgenic mice
(Pena et al, 1997) affected the differentiation process. Al-
though these results may appear to contradict our hypoth-
esis, they in fact support it. In each case, experimental
manipulations did not affect spatial and temporal presence
of Bcl-2 in the basal cells, where it may function as an in-
hibitor of mitochondrial impairments, preventing premature
K10 expression and differentiation.
We suggest that Bcl-2 and K10 cooperate at the border
between proliferation and differentiation. In this case, K10,
unlike other markers of differentiation, may play a regulatory
role in addition to its structural function, as recently dem-
onstrated by others (Reichelt and Magin, 2002; Santos et al,
2002). According to this scenario, K10-positive cells should
have and do have (these data and Allombert-Blaise et al,
2003; Ronquist et al, 2003) depolarized mitochondria. Not
surprisingly, unable to utilize the respiratory chain to pro-
duce energy, keratinocyte energy metabolism is predomi-
nantly anaerobic (Ronquist et al, 2003), perhaps as a
consequence of the limited availability of oxygen and nu-
trients to cells migrating away from the capillary system.
This may create conditions reminiscent of hypoxia and
growth factor withdrawal, both of which induce mi-
tochondrial impairment and apoptosis in many experimen-
tal models but differentiation in keratinocytes.
Drugs triggering mitochondrial dysfunction induce K10
in differentiation-competent cells and apoptosis in
keratinocytes not yet primed to undergo differentia-
tion K10 induction was accompanied by some apoptosis,
which occurred in two waves: before and after K10 induc-
tion. This suggests that the same stimuli induced apoptosis
in some cells and differentiation in others. Because apo-
ptotic cells were found mainly among attached K10-nega-
tive cells, whereas apoptotic-like nuclei were found mainly
in the detached cells, the majority of which expressed K10,
we propose that PPIX, STS, and ROT induced apoptosis in
differentiation-incompetent cells, whereas competent cells
induce K10 and detached either as a consequence of ad-
vanced stratification or apoptosis induced by too long an
exposure to the drug (lethal dose), or both. Although our
study cannot discriminate between these possibilities, the
important point is that, if this scenario is correct, the same
mitochondria-dependent machinery can induce either clas-
sical apoptosis or differentiation, depending on the cellular
background.
Thus, it is likely that in human epidermis, under normal
conditions, the mitochondria-dependent cell death pathway
is required for the induction of differentiation markers and
differentiation-associated changes leading to cell death.
Classical apoptosis would then occur when the conditions
become abnormal. Further studies are needed to confirm
this conclusion. Very recently it has been shown that the
apoptotic pathway also plays an important role in signaling
lens cell differentiation (Weber and Menko, 2005).
Material and Methods
Cell cultures NHK were obtained from adult skin discarded after
breast reduction surgery, and was used according to the Decla-
ration of Helsinki Principles and the guidelines of ethical committee
of the Medical Center, CHRU Lille prepared in agreement with the
French law. After overnight incubation in dispase (1 U per mL),
digestion at 41C, followed by trypsinization of the separated ep-
idermis, cells were plated and grown in a keratinocyte-defined
SFM-supplemented medium (Gibco Invitrogen Corp., Cergy
Pontoise, France). To induce apoptosis-associated mitochondrial
changes, keratinocyte cultures were fed with SFM plus PPIX, STS,
ROT, and calcium (all from Fluka Sigma, Saint Quentin Fallavier,
France) for the indicated time and concentrations in the presence
or absence of antioxidants: 250 mM a tocopherol (vitamin E) (Sigma,
Saint Quentin Fallavier, France), 500 U per mL catalase, and 2.5 mM
DPPD (Calbiochem, Strasbourg, France) or calcium chelator 2.5 mM
BAPTAAM (Molecular Probes, Montlucon, France). HaCaT human
immortalized keratinocytes were obtained from Dr Norbert Fusenig
(DKFZ Heidelberg, Germany) and propagated in DMEM (Gibco In-
vitrogen Corp.) with 10% FCS as in Boukamp et al (1988). HaCaT
cells stably overexpressing Bcl-2 were made in our laboratory as
described in Haake and Polakowska (1995). For calcium-induced
differentiation CaCl2 was added (final concentration 1.2 mM) to
HaCaT cultures pre-grown in SFM. For colony-forming assay, after
24 h of treatment, cells were trypsinized, counted, and re-plated at
low density in six-well tissue culture plates. Seven days later, col-
onies were counted and colony-forming efficiency was calculated
as the percent of colonies formed to the total number of plated life
cells (trypan blue negative).
Western blot For detection of cytochrome c and AIF release,
cytosolic protein extracts were prepared by Dounce homogeniza-
tion of cultured keratinocytes in a hypotonic buffer, as previously
described (Gallego et al, 2004). Western blot was performed ac-
cording to standard procedures using 1:1000 K10 (Progen, Eury,
France) and involucrin (Novocastra, Antony, France) monoclonal
antibodies. The cytochrome c band was revealed with anti-cyto-
chrome c monoclonal antibody (1:1000) (Pharmingen, Saint
Quentin en Yuelline, France, clone 7H8.2C12) recognizing the de-
natured form of cytochrome c. For detection of AIF, a monoclonal
antibody (1:1000) from Santa Cruz Biotechnologies (Le Perray en
Yuelline, France) was used. The G3PDH polyclonal rabbit antibody
(Interchim, Montlucon, France) was used (1:2000) for the loading
standardization. Specific bands were visualized using peroxidase-
conjugated secondary antibody and the enhanced chemilumines-
cence reagent (Amersham, Orsay, France).
Flow cytometry For mitochondrial mass, cells were incubated
with 50 nM MTG. To measure mitochondrial membrane potential
(DCm) and ROS production, cationic 40 nM 3,30dihexyloxa-
carbocyanineiodide (Dioc6(3)) and 2.5 mM dihydroethidium (HE)
were used, respectively. Intracellular-free calcium levels were
measured using 500 nM Fluo-3, AM calcium indicator. All stain-
ings were performed as recommended by the supplier (Molecular
Probes Inc., Interchim). Control experiments were performed in the
presence of 50 mM carbonyl cyanide m-chlorophenylhydrazone (15
min, 371C), an uncoupling agent that abolishes the DCm, and in
1 mM menadione for 1 h as a control for ROS production. To mea-
sure DCm we also used a CMXRos (50 nM) probe with comparable
initial results but selected Dioc6(3) for the convenience of its green
fluorescence. We checked that Dioc6(3) at the concentration used
does not inhibit keratinocyte respiration using the High-Resolution
Respiratory Oxygraph 2000 (Oroboros Inst, Innsbruck, Austria). For
K10 detection, 5  105 cells fixed in ice-cold 70% ethanol were
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incubated with K10 primary antibody during 45 min at room tem-
perature and with secondary antibody conjugated with FITC (Jack-
son Immuno Research, Interchim, Montlucon, France) for 30 min at
41C before analysis by flow cytometry. For the cell cycle analysis,
5  105 ethanol-fixed cells were centrifuged and resuspended in 1
mL PBS containing 50 mg per mL PI and 100 mg per mL RNase
(Sigma). All flow cytometry experiments were performed on a
Coulter XL3 cytofluorometer (Coulter Corp., Hialeah, Florida). For
all cytofluorometric experiments, forward and side scatters were
gated on the major population of cells, and a minimum of 50,000
cells were analyzed.
Immunoﬂuorescence detection Cells were grown in chamber
slides and treated as indicated in the text. They were fixed in 4%
paraformaldehyde 10 min at room temperature (RT), permeabilized
in Triton X-100 solution (0.1%) during 10 min at RT, and then
stained 1 h at RT with the indicated antibodies. For K10 immuno-
staining the monoclonal antibody from Progen was used (dilution
1:10). All slides were washed three times in PBS and incubated
with mouse or rabbit secondary antibodies conjugated with FITC
or Texas Red for 45 min at RT. Nuclei were visualized by 406-
diamidino-2-phenylindole (DAPI) staining. Samples were rinsed,
coverslipped using Vectashield mounting medium, and immedi-
ately examined by fluorescence microscopy.
RT-PCR Cells were treated with PPIX 30 mM, STS 5 nM, or ROT
0.25 mM for 24 h. After harvesting by trypsinization, total RNA ex-
traction was performed using RNABIe (Eurobio, Les Lilis, France)
according to the supplier’s recommendations. Total RNA was re-
versed transcribed into first-strand cDNA using oligo dT primer.
The set of sense and anti-sense primers was used to detect K10
transcript, and b-actin to standardize the RT-PCR reaction. Ampli-
fication (30 cycles) was performed using GeneAmp PCR System
2400, Perkin-Elmer Cetus thermocycle. The expected 167 bp K10
and 223 bp actin RT-PCR products were visualized on 1.4% ag-
arose gel with ethidium bromide.
Transfection HaCaT or NHK cells 5  104 per well of chamber
slides were transfected, either with empty vector or with the K10
CAT (a gift from Dr M. Blumenberg) or NF-kB-Luc (Clonetech, Saint
Quentin en Yuelline, France) reporter vectors, using lipofectamine
2000 (Invitrogen, Cergy Pontoise, France) in DMEM without serum
according to the manufacturer’s instructions. To measure K10 or
NF-kB promoter activities, transfected cell lysates were assayed
using colorimetric enzyme immunoassay for the quantitative de-
termination of chloramphenicol acetyltransferase (CAT ELISA Kit,
Roche, Meylan, France) or Bright-Glo Luciferase Assay System
(Promega, Charbonnieres, France), respectively, according to the
manufacturers’ instructions. Samples were standardized accord-
ing to the protein content and transfection efficiency.
Transmission EM HaCaT cells were treated with PPIX for 24 h.
Cells were harvested, and fixed with 2.5% glutaraldehyde in ca-
codylate buffer. Post-fixation was performed in 1% osmic acid and
ethanol dehydrated cells were embedded in Epon/propylen buffer
(vol/vol). Human skin samples were fixed with 2% paraformalde-
hyde, 0.4% picric acid, and 1% glutaraldehyde in 0.1 M phosphate
buffer, dehydrated in ethanol, treated with propylene oxide, and
embedded in Araldite. Sections of cells and skin were collected on
parlodion-carbon-coated nickel and stained with 2% uranyl ace-
tate in water, then with lead citrate, and observed with a Zeiss (Le
Pecq, France) electron microscope.
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